Home/ Stocks/ PSNL

Personalis, Inc. Common Stock

PSNL XNAS

$14.16 +0.85 (+6.52%) ▲ 15-min delayed

Open

$13.24

High

$14.30

Low

$13.13

Volume

3.21M

Market Cap

$1.39B

About Personalis, Inc. Common Stock

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Sector: SERVICES-MEDICAL LABORATORIES Employees: 260 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$22.36M	$-31,683,000	$-0.30
Q1 2026	$15.47M	$-30,032,000	$-0.29
FY 2025	$69.65M	$-81,270,000	$-0.91
Q3 2025	$14.49M	$-21,652,000	$-0.24

Earnings & Analyst Ratings

Next Earnings: Mon, Nov 2, 2026

Calendar →

Related Market News

No specific coverage for PSNL yet. Check out our latest market news or earnings calendar.

Get PSNL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Personalis, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.